Hanson v. U.S., 76-1156

Decision Date26 August 1976
Docket NumberNo. 76-1156,76-1156
Citation540 F.2d 947
PartiesDon HANSON and Donna W. Schuster, Appellants, v. UNITED STATES of America et al., Appellees.
CourtU.S. Court of Appeals — Eighth Circuit

James Malcolm Williams, Minneapolis, Minn., on brief, for appellants.

Robert G. Renner, U. S. Atty., and Daniel M. Scott, Asst. U. S. Atty., Minneapolis, Minn., on brief, for appellees.

Before BRIGHT, STEPHENSON and HENLEY, Circuit Judges.

PER CURIAM.

This appeal arises from the district court's 1 denial of appellants' request for a preliminary injunction. Appellants are commercial distributors of Laetrile (Vitamin B-17), which they claim to be effective in the prevention, control, arrest and minimization of cancerous tissue growths. They sought injunctive and declaratory relief in the district court preventing United States authorities from interfering in any way with the distribution of Laetrile. 2 Specifically, appellants requested the enjoining of criminal prosecutions, search warrants and civil seizures, and an end to official statements against them.

It is undisputed that Laetrile has not been approved for distribution by the Food and Drug Administration. See 21 U.S.C. § 355(a). In denying preliminary injunctive relief, the district court essentially held that appellants had not demonstrated a substantial probability of success with respect to their claim that Laetrile is not a substance subject to control within the meaning of the Food, Drug and Cosmetic Act. See 21 U.S.C. §§ 321(g)(1) and 321(p)(1).

After reviewing the record we conclude that the district court did not abuse its discretion in denying preliminary injunctive relief. We affirm on the basis of the district court's well-reasoned opinion reported at 417 F.Supp. 30 (D.Minn.1976).

Affirmed.

1 The Honorable Earl R. Larson, United States District Judge for the District of Minnesota.

2 On January 9, 1976, appellants were indicted on charges of smuggling vials and tablets of Laetrile in violation of 18 U.S.C. §§ 371 and 545.

To continue reading

Request your trial
9 cases
  • Association of Amer. Phys. v. U.S. Food and Drug
    • United States
    • U.S. District Court — District of Columbia
    • October 17, 2002
    ...and any other relevant source." Harris, 655 F.2d at 239 (quoting Hanson v. United States, 417 F.Supp. 30, 35 (D.Minn.) aff'd 540 F.2d 947 (8th Cir.1976)).19 Under this line of cases, to discern "manufacturer intent" courts can look to "evidence that the vendor is aware that his product is b......
  • National Nutritional Foods Ass'n v. Mathews
    • United States
    • U.S. Court of Appeals — Second Circuit
    • June 7, 1977
    ...cert. denied, 353 U.S. 976, 77 S.Ct. 1058, 1 L.Ed.2d 1136 (1957); Hanson v. United States, 417 F.Supp. 30, 34 (D.Minn.), aff'd, 540 F.2d 947 (8th Cir. 1976); United States v. 2 Cartons, More or Less, No. 26 Formula GM, 132 F.Supp. 569, 573 In determining whether an article is a "drug" becau......
  • U.S. v. Travia
    • United States
    • U.S. District Court — District of Columbia
    • November 30, 2001
    ...relevant source.'" Action on Smoking, 655 F.2d at 239 (quoting Hanson v. United States, 417 F.Supp. 30, 35 (D.Minn.), affirmed 540 F.2d 947 (8th Cir.1976)). But, contend the defendants, the gravamen of the charge against them here is that there was no labeling on the balloons they sold. By ......
  • Custody of a Minor
    • United States
    • United States State Supreme Judicial Court of Massachusetts Supreme Court
    • August 9, 1979
    ...1978); Gadler v. United States, 425 F.Supp. 244, 247 (D.Minn.1977); Hanson v. United States, 417 F.Supp. 30, 36 (D.Minn.), aff'd 540 F.2d 947 (8th Cir. 1976); United States v. General Research Laboratories, 397 F.Supp. 197, 198-199 (C.D.Cal.1975). See Note, Laetrile: Statutory and Constitut......
  • Request a trial to view additional results
2 books & journal articles

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT